Skip to main content
ATNM logo
ATNM
(NYSEAMERICAN)
Actinium Pharmaceuticals, Inc.
$0.89-- (--)
Loading... - Market loading

Actinium Pharmaceuticals (ATNM) Stock Price & Financial Analysis

Actinium Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.89 - $0.91
52-Week High$1.87
52-Week Low$0.88
Open$0.91
Volume130.27K
Average Volume (3M)112.88K
Market Cap27.83M
Shares Outstanding31.24M
Price to Sales (P/S)309.25
Price to Book (P/B)12.08
EV/EBITDA0.54
Revenue (TTM)90.00K
Net Income (TTM)-23.47M
Free Cash Flow (TTM)-22.98M
EPS (TTM)$-0.75
Profit Margin-26078.89%
Operating Margin-28346.67%
Return on Equity (ROE)-1018.71%
Debt to Equity0.66
50-Day MA$1.05
200-Day MA$1.24
52-Week Change-52.35%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Actinium Pharmaceuticals

What is the current stock price for ATNM?

As of the latest trading session, ATNM stock trades at $0.89. The 52-week range is $0.88–$1.87, with a day range of $0.89–$0.91.

What is the P/E ratio for ATNM?

The P/E ratio (Price-to-Earnings) for ATNM is shown in the Key Statistics section. This valuation metric helps compare Actinium Pharmaceuticals, Inc. to industry peers.

Does ATNM pay dividends?

Actinium Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ATNM?

Analyst ratings and recommendations for ATNM are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of ATNM?

Actinium Pharmaceuticals's market capitalization is $27.8M, classifying it as a micro-cap company. Actinium Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.